These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22869726)

  • 1. General and inducible hypermutation facilitate parallel adaptation in Pseudomonas aeruginosa despite divergent mutation spectra.
    Weigand MR; Sundin GW
    Proc Natl Acad Sci U S A; 2012 Aug; 109(34):13680-5. PubMed ID: 22869726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of Rif(r) mutations in Pseudomonas aeruginosa and Pseudomonas putida.
    Jatsenko T; Tover A; Tegova R; Kivisaar M
    Mutat Res; 2010 Jan; 683(1-2):106-14. PubMed ID: 19887074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic Emergence of Mismatch Repair Deficiency Facilitates Rapid Evolution of Ceftazidime-Avibactam Resistance in Pseudomonas aeruginosa Acute Infection.
    Khil PP; Dulanto Chiang A; Ho J; Youn JH; Lemon JK; Gea-Banacloche J; Frank KM; Parta M; Bonomo RA; Dekker JP
    mBio; 2019 Sep; 10(5):. PubMed ID: 31530672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic adaptation of Pseudomonas aeruginosa to the airways of cystic fibrosis patients is catalyzed by hypermutation.
    Mena A; Smith EE; Burns JL; Speert DP; Moskowitz SM; Perez JL; Oliver A
    J Bacteriol; 2008 Dec; 190(24):7910-7. PubMed ID: 18849421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Essential Role of Hypermutation in Rapid Adaptation to Antibiotic Stress.
    Mehta HH; Prater AG; Beabout K; Elworth RAL; Karavis M; Gibbons HS; Shamoo Y
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31036684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Hypermutator Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis in Australia.
    Rees VE; Deveson Lucas DS; López-Causapé C; Huang Y; Kotsimbos T; Bulitta JB; Rees MC; Barugahare A; Peleg AY; Nation RL; Oliver A; Boyce JD; Landersdorfer CB
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the
    Hall KM; Pursell ZF; Morici LA
    Front Cell Infect Microbiol; 2022; 12():943346. PubMed ID: 35937684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ongoing evolution of Pseudomonas aeruginosa PAO1 sublines complicates studies of DNA damage repair and tolerance.
    Sidorenko J; Jatsenko T; Kivisaar M
    Mutat Res; 2017 Mar; 797-799():26-37. PubMed ID: 28340408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linking system-wide impacts of RNA polymerase mutations to the fitness cost of rifampin resistance in Pseudomonas aeruginosa.
    Qi Q; Preston GM; MacLean RC
    mBio; 2014 Dec; 5(6):e01562. PubMed ID: 25491352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational neighbourhood and mutation supply rate constrain adaptation in Pseudomonas aeruginosa.
    Hall AR; Griffiths VF; MacLean RC; Colegrave N
    Proc Biol Sci; 2010 Feb; 277(1681):643-50. PubMed ID: 19889704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotypic and phenotypic analyses of a Pseudomonas aeruginosa chronic bronchiectasis isolate reveal differences from cystic fibrosis and laboratory strains.
    Varga JJ; Barbier M; Mulet X; Bielecki P; Bartell JA; Owings JP; Martinez-Ramos I; Hittle LE; Davis MR; Damron FH; Liechti GW; Puchałka J; dos Santos VA; Ernst RK; Papin JA; Albertí S; Oliver A; Goldberg JB
    BMC Genomics; 2015 Oct; 16():883. PubMed ID: 26519161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA Polymerases ImuC and DinB Are Involved in DNA Alkylation Damage Tolerance in Pseudomonas aeruginosa and Pseudomonas putida.
    Jatsenko T; Sidorenko J; Saumaa S; Kivisaar M
    PLoS One; 2017; 12(1):e0170719. PubMed ID: 28118378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Environmental variation alters the fitness effects of rifampicin resistance mutations in Pseudomonas aeruginosa.
    Gifford DR; Moss E; MacLean RC
    Evolution; 2016 Mar; 70(3):725-30. PubMed ID: 26880677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections.
    Maciá MD; Blanquer D; Togores B; Sauleda J; Pérez JL; Oliver A
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3382-6. PubMed ID: 16048951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic adaptation of Pseudomonas aeruginosa during chronic lung infection of patients with cystic fibrosis: strong and weak mutators with heterogeneous genetic backgrounds emerge in mucA and/or lasR mutants.
    Ciofu O; Mandsberg LF; Bjarnsholt T; Wassermann T; Høiby N
    Microbiology (Reading); 2010 Apr; 156(Pt 4):1108-1119. PubMed ID: 20019078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypermutation and the preexistence of antibiotic-resistant Pseudomonas aeruginosa mutants: implications for susceptibility testing and treatment of chronic infections.
    Oliver A; Levin BR; Juan C; Baquero F; Blázquez J
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4226-33. PubMed ID: 15504845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of the rpoB gene to determine the specificity of base substitution mutations on the Escherichia coli chromosome.
    Garibyan L; Huang T; Kim M; Wolff E; Nguyen A; Nguyen T; Diep A; Hu K; Iverson A; Yang H; Miller JH
    DNA Repair (Amst); 2003 May; 2(5):593-608. PubMed ID: 12713816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mismatch repair system (mutS, mutL and uvrD genes) in Pseudomonas aeruginosa: molecular characterization of naturally occurring mutants.
    Oliver A; Baquero F; Blázquez J
    Mol Microbiol; 2002 Mar; 43(6):1641-50. PubMed ID: 11952911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotypic and phenotypic variation in Pseudomonas aeruginosa reveals signatures of secondary infection and mutator activity in certain cystic fibrosis patients with chronic lung infections.
    Warren AE; Boulianne-Larsen CM; Chandler CB; Chiotti K; Kroll E; Miller SR; Taddei F; Sermet-Gaudelus I; Ferroni A; McInnerney K; Franklin MJ; Rosenzweig F
    Infect Immun; 2011 Dec; 79(12):4802-18. PubMed ID: 21930755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of Pseudomonas aeruginosa Antimicrobial Resistance and Fitness under Low and High Mutation Rates.
    Cabot G; Zamorano L; Moyà B; Juan C; Navas A; Blázquez J; Oliver A
    Antimicrob Agents Chemother; 2016 Jan; 60(3):1767-78. PubMed ID: 26729493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.